Drug and medical gadget giant Johnson & Johnson, Inc. (J&J) revealed on February 28, 2021, intends to examine its experimental Ad26.COV2.S vaccination for COVID-19 on infant youngsters (including infants), expectant women and individuals with jeopardized immune systems.
J&J did not include babies, expectant women or the immunocompromised in the U.S. population in clinical tests on the speculative COVID-19 injection in 2015.1,2,3 A recent write-up in New York Magazine kept in mind:4.
” The initial scientific tests for COVID-19 vaccines didn’t consist of children, which is common practice; now, trials for more youthful kids are occurring in coming down order old, calibrating the best dose for every cohort.”.
The announcement by J&J came the day after the U.S. Food and Drug Administration (FDA) provided J&J subsidiary Janssen Biotech Inc. an emergency situation usage consent (EUA) to disperse the vaccination in the U.S. for use by individuals 18 years of age and older. Presently, the single-dose Ad26.COV2.S vaccine can not be offered to anyone in the U.S. under 18 years of ages.5,6,7,8,9.
According to an agent for Janssen, which makes Ad26.COV2.S, the single-dose vaccination will certainly initially be evaluated on kids between 12 and 18 years old. Afterward, J&J will continue rapidly to examine the vaccine on babies, immunocompromised people and pregnant females.10.
FDA Reviewed J&J Plans to Test COVID-19 Vaccine on Babies.
J&J’s relocate to check its COVID-19 injection on extremely children, as well as pregnant lady and immunocompromised individuals, was expected. The plans to do these professional trials were reportedly included in J&J’s application to the FDA for EUA and were reviewed by members of the FDA consultatory board that assessed J&J’s data on Ad26.COV2.S.11,12.
” They (J&J) did not get into a lot of information about it however did make it clear they will be pursuing maternal and pediatric coronavirus immunization research studies,” said FDA advisory board participant Dr. Ofer Levy, Ph.D., supervisor of the Precision Vaccines Program at Harvard University’s Boston Children’s Hospital.13.
Other Companies Testing COVID-19 Vaccines on Older Children.
J&J’s planned COVID-19 injection medical tests will be the first to consist of babies. AstraZeneca plc, which has produced the experimental AZD1222 injection for COVID-19 in collaboration with Oxford University, has actually been conducting medical tests on youngsters as young as 6 years old, while Moderna Inc. and Pfizer Inc. (in collaboration with BioNTech SE) are presently evaluating their experimental mRNA-1273 and BNT162b2 COVID-19 injections on kids as young as 12.14,15.
J&J started shipping 4 million dosages of Ad26.COV2.S on March 1, 2021. The company has promised that it will certainly have 20 million dosages of the injection all set to distribute by the end of March and 100 million doses by this summer season.16
http://articles.mercola.com/sites/articles/archive/2021/03/16/covid-19-vaccine-tested-on-babies-and-pregnant-women.aspx